But an association with improved overall survival failed to reach statistical significance ...

Metastasis-directed therapy for oligometastatic prostate cancer was associated with improved outcomes in a systematic review and meta-analysis.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

A CUTTING-EDGE cold laser therapy could effectively treat prostate cancer and slash the risk of any debilitating side effects ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...

CEDAR RAPIDS, Iowa — Mercy Medical Center has introduced a new non-invasive treatment for men with localized prostate cancer ...

“Oxybutynin demonstrated clear and clinically meaningful improvements in both hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer,” said lead researcher Dr.

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...